Alice Turner
@AlphaCopdDoc
Professor & Consultant Respiratory Med, @PSRC_Midlands director. @NRAPaudit #QI lead. @AlphaFriend board member. Clinical & research #AATD #COPD.
You might like
Missed our recent #AATD live event from Amsterdam? Watch the onDemand video to get insights on proactive screening, cross-specialty collaboration, and the current treatment landscape. #PeerVoice #meded #AATD #pulmonology #hepatology peervoice.com/XSX?PromoCode=…
The A1F team kicked off #Alpha1Awareness Month and the A1F Virtual Walk 2025 together at our Coral Gables office! The energy is high and we are ready for a month of awareness, advocacy, and community. Join us and be part of the movement: alpha1.org/november-is-al…
Here’s a reminder of the #WMPAMatMed programme happening at UHCW next month Features talks on chest pain, headache and endocrine emergencies, plus research abstracts, case reports and posters in adult general internal medicine Register here: millbrook-events.co.uk/event/WMPAMate…
Great day with @NIHRPSRCs discussing safety equity. Loved the live graphics summarising talks (@PSRC_Midlands highlights 👇🏻) and the summary of maternal care pathway through an equity lens
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease PM2.5 and its constituents are associated with differential DNA methylation in the blood of patients with fibrotic ILD @atscommunity 🔗 tinyurl.com/2rk6wwmn
Genetic risk factors for disease susceptibility differ from those for progression/survival nature.com/articles/s4158…
Great talk on microplastics & lung health #ERSCongress2025 Key messages - more ingestion from air than gut, thus most deposition in the lung. Links to #COPD & ILD. The type of plastic matters
Methods to prevent respiratory disease and it's impacts, from #airquality interventions, case finding, lifestyle & more - summarised by @WHO in this report focussed on Europe #ERSCongress2025 who.int/europe/publica…
Shifting thinking toward prevention as the most cost-effective strategy in #copd Sounds sensible but not easy in many health systems #ERSCongress2025
Join us for our next SafetyNet webinar: Understanding and measuring emergency doctors’ tolerance of clinical uncertainty on Wednesday 12 November 🔗Book your place: psrc-network.nihr.ac.uk/2025/09/09/s... @drwilliamlea @NIHRPSRCs #emergencymedicine
ALIENTO study of Astegolimab, targeting IL33 in #COPD. Marginal effect on AECOPD, direction same as (negative) ARNASA study. Maybe too broad/late population? #ERSCongress2025
Started #ERSCongress2025 with an excellent NTM session. Take homes: many new routes to Rx, CFTR & GM-CSF clinical data promising. BACES score aids prognostication
"We" need clinical trials & translational research, but the urgent gap is in health services & implementation science. We know much of what works; the challenge is delivering it equitably, affordably, and sustainably. Research must meet reality.
Treatable traits! New! We compare inflammation, microbiome, rheology and mucins in asthma, COPD, bronchiectasis, CF and controls. Huge overlap in biology but clear neutrophilic and T2 endotypes in all diseases! Endotypes>disease labels @accpchest journal.chestnet.org/article/S0012-…
Original research shows that preserved ratio impaired spirometry (PRISm) was associated with transition into airway obstruction corresponding to #COPD within one decade. Read more in the August issue of the journal CHEST®: hubs.la/Q03DXNyt0 #MedEd #JournalCHEST
🚑 Maximising Ambulance Referrals into virtual wards via Single Point of Access (SPOA). Dr Shelagh O’Riordan will be in conversation with ambulance & A&E colleagues exploring streamlining ambulance referrals into virtual care. 📅 Register: ow.ly/rL0X50WFieM @jupiterhouse1
Personalised digital self-management may improve QOL - our latest trial in #COPD doi.org/10.1080/154125…
Learnt a lot from reviewing this via my role with @BTSrespiratory standards of care committee. Check it out
Stay up to date with the latest best practise in Aspergillus-related care with the @BTSrespiratory Clinical Statement. Explore the resource 👉 brit-thoracic.uk/RFAspergillus0…
We need a driven and enthusiastic scientist with an interest in Respiratory immunology to support our 4 year study examining the impact of e-cigarettes on lung health, EVALUATE. Apply using the link below or email me for a chat about our project. edzz.fa.em3.oraclecloud.com/hcmUI/Candidat…
United States Trends
- 1. Packers 97.4K posts
- 2. Eagles 126K posts
- 3. Jordan Love 15K posts
- 4. #WWERaw 130K posts
- 5. LaFleur 14.3K posts
- 6. Benítez 10.9K posts
- 7. $MONTA 1,317 posts
- 8. AJ Brown 6,922 posts
- 9. Jalen 23.9K posts
- 10. Jaelan Phillips 7,809 posts
- 11. McManus 4,348 posts
- 12. Patullo 12.3K posts
- 13. Sirianni 5,001 posts
- 14. Smitty 5,513 posts
- 15. Grayson Allen 3,689 posts
- 16. #GoPackGo 7,895 posts
- 17. James Harden 1,774 posts
- 18. Cavs 11.5K posts
- 19. Vit Krejci N/A
- 20. Berkeley 55.4K posts
You might like
-
British Association for Lung Research (BALR)
@BALRcommunity -
INSPIREresp
@INSPIREresp_UK -
Team Respiratory UoB
@TeamRespiratory -
John Hurst
@ProfHurst -
PCRS
@PCRSUK -
National Respiratory Audit Programme
@NRAPaudit -
Rachael Evans
@REvans_Breathe -
Ian Jarrold
@IanJarroldALUK -
Surya P Bhatt, MD, MSPH
@suryapbhatt -
Dhruv Parekh
@drdhruvparekh -
Will
@toplungdoc -
Hitasha Rupani
@tasha_rupani -
Anant Patel
@veggielungdoc -
Don Sin
@donsin4 -
Akhilesh Jha
@Akhilesh_Jha
Something went wrong.
Something went wrong.